Latest filing published 26 Mar 2018 for CanniMed Therapeutics Inc..
Larry Holbrook appears in our data through filings on CanniMed Therapeutics Inc. shares, published by SEDI. In total, 14 filings cover trades dated from 1 November 2016 to 24 March 2018.
Every open-market trade on record is a sale: 10 sales worth €291k. Other entries cover 2 option exercises. 2018 to date brings no purchases and 1 sale.
The newest entry dates from 26 March 2018: a transaction, in CanniMed Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations